AnaSpec, a worldwide provider of integrated proteomics solutions, announced today that the name of their flagship line of high-performance assay kits has been changed from EnzoLyte to SensoLyte™. AnaSpec sales & marketing manager, Violeta Rajkovska, MBA, noted, “The new name demonstrates AnaSpec’s commitment to providing assay kits with the highest sensitivity available in the industry. We expect that the SensoLyte™ name will become synonymous with industry-leading sensitivity and performance.”
The SensoLyte™ line includes assay kits designed for the screening of renin inhibitors, HCV & HIV proteases, matrix metalloproteinases (MMPs), caspases, protein kinases, and protein phosphatases.
For more information visit www.anaspec.com
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies:
AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. In conjunction, AnaSpec provides premier custom services including peptide synthesis, antibody production, and assay development.
Established in 1993, AnaSpec's ISO9001:2000 certified headquarters and manufacturing facilities are located in San Jose, CA.
